Related Experiment Video

Updated: Apr 27, 2026

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration
07:03

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration

Published on: May 4, 2017

73.8K

Effects of bronchoalveolar lavage on refractory Mycoplasma pneumoniae pneumonia

Yuanyuan Zhang1, Ying Chen1, Zhimin Chen2

  • 1Department of Pulmonology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.

Respiratory Care
|June 26, 2014
PubMed
Abstract

Insights

Early bronchoalveolar lavage (BAL) significantly improved outcomes for children with refractory Mycoplasma pneumoniae pneumonia. This early intervention reduced fever duration and hospitalization, demonstrating its therapeutic benefit.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Refractory Mycoplasma pneumoniae pneumonia in children can present with large pulmonary lesions.
  • Early diagnosis and intervention are crucial for managing severe pediatric respiratory infections.

Purpose of the Study:

  • To evaluate the efficacy of early bronchoalveolar lavage (BAL) in children with refractory Mycoplasma pneumoniae pneumonia.
  • To compare the clinical outcomes of early versus late BAL administration.

Main Methods:

  • A prospective study involving 35 children with refractory M. pneumoniae pneumonia.
  • Children were divided into an early BAL group (within 3 days) and a late BAL group (after 3 days).
  • Clinical symptoms, laboratory findings, and radiological resolution were compared between groups.

Main Results:

  • All patients showed improvement after BAL therapy.
  • The early BAL group had significantly shorter median fever duration (4 days vs. 5 days) and hospitalization (7 days vs. 10 days).
  • Early BAL led to quicker resolution of atelectasis (67% vs. 14%) and faster recovery of laboratory indices.

Conclusions:

  • Bronchoalveolar lavage (BAL) is an effective and safe treatment for refractory M. pneumoniae pneumonia in children.
  • Early application of BAL (within 3 days) appears more beneficial, leading to improved clinical and radiological outcomes.
Keywords:
bronchoalveolar lavagechildrenflexible bronchoscopymycoplasma pneumoniapneumoniarefractory

More Related Videos

Bronchoalveolar Lavage BAL for Research; Obtaining Adequate Sample Yield11:47

Bronchoalveolar Lavage BAL for Research; Obtaining Adequate Sample Yield

Published on: March 24, 2014

75.1K
The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice12:27

The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice

Published on: April 2, 2014

16.2K

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
80
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
22
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.2K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K